Pharmaceutical Technology-06-02-2007

Pharmaceutical Technology
Agent-In-Place

June 02, 2007

Look ahead to keep from falling behind.

Pharmaceutical Technology

Pharma companies and CMOs build positions in mAbs.

Pharma Capsules
Pharmaceutical Technology

June 02, 2007

News and Views

Pharmaceutical Technology

Nanotechnology is emerging as a tool for resolving challenges in delivering poorly water soluble and highly potent drugs.

Pharmaceutical Technology
This Time Around

June 02, 2007

Global corporate citizenship can go a long way.

Pharmaceutical Technology

Pharmaceutical Technology's Annual Manufacturers' Rankings provides perspectives on revenues, product positioning, R&D spending, pharmaceutical manufacturing activity, and capital projects of the major drug companies.

The racemic compound (R, S)-(±)-ibuprofen is a popular and well understood active pharmaceutical ingredient, but it has several disadvantageous formulation properties such as poor solubility, low melting point, and potential esterification with excipients containing an hydroxyl group. The authors investigate the use of an (R, S)-(±)-ibuprofen salt to evaluate these problems using various analytical methods to determine the polymorphism, crystallinity, and drying scheme.

Pharmaceutical Technology

Product characterization and production challenges are key issues in developing a pathway for biosimilar therapies.

Pharmaceutical Technology
Outsourcing

June 02, 2007

While some companies float with the tide, others grab market share while business is good.

Pharmaceutical Technology
In the Spotlight

June 02, 2007

Editors' Picks of Pharmaceutical Science & Technology Innovations

Pharmaceutical Technology
From The Editor

June 02, 2007

Perhaps Congress can help FDA meet its multiple oversight demands.

Pharmaceutical Technology
Packaging Forum

June 02, 2007

Exhibitors' products prevent counterfeiting, provide child resistance, protect product quality, and improve packaging-line efficiency.

Pharmaceutical Technology

Signature authentication technology has evolved to become a stong tool for improving confidence in verification.

Pharmaceutical Technology
In the Field

June 02, 2007

Boston, MA (May 8)-The global biotechnology industry showed several positive signs in 2006, including increases in overall revenues and financing, although the industry as a whole continues to operate at a loss, according to Ernst & Young's (New York, NY, www.ey.com) annual analysis of the biotechnology industry. Its report, "Beyond Borders 2007," was issued at the Biotechnology Industry Organization's (BIO, www.bio.org) annual conference and exhibition, which was held in Boston May 6–9.